BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 16911685)

  • 1. Secretion of RANTES (CCL5) and interleukin-10 from mesenteric adipose tissue and from creeping fat in Crohn's disease: regulation by steroid treatment.
    Schäffler A; Fürst A; Büchler C; Paul G; Rogler G; Schölmerich J; Herfarth H
    J Gastroenterol Hepatol; 2006 Sep; 21(9):1412-8. PubMed ID: 16911685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor secretion from mesenteric adipose tissue and from creeping fat in Crohn's disease.
    Schäffler A; Fürst A; Büchler C; Paul G; Rogler G; Schölmerich J; Herfarth H
    J Gastroenterol Hepatol; 2006 Sep; 21(9):1419-23. PubMed ID: 16911686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiling adipocytokine secretion from creeping fat in Crohn's disease.
    Paul G; Schäffler A; Neumeier M; Fürst A; Bataillle F; Buechler C; Müller-Ladner U; Schölmerich J; Rogler G; Herfarth H
    Inflamm Bowel Dis; 2006 Jun; 12(6):471-7. PubMed ID: 16775490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of leptin mRNA in mesenteric adipose tissue in inflammatory bowel diseases.
    Barbier M; Vidal H; Desreumaux P; Dubuquoy L; Bourreille A; Colombel JF; Cherbut C; Galmiche JP
    Gastroenterol Clin Biol; 2003 Nov; 27(11):987-91. PubMed ID: 14732844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of adiponectin, an anti-inflammatory protein, in mesenteric adipose tissue in Crohn's disease.
    Yamamoto K; Kiyohara T; Murayama Y; Kihara S; Okamoto Y; Funahashi T; Ito T; Nezu R; Tsutsui S; Miyagawa JI; Tamura S; Matsuzawa Y; Shimomura I; Shinomura Y
    Gut; 2005 Jun; 54(6):789-96. PubMed ID: 15888786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal proinflammatory cytokine and chemokine expression of gastroduodenal lesions in Crohn's disease.
    Moriyama T; Matsumoto T; Jo Y; Yada S; Hirahashi M; Yao T; Iida M
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():85-91. PubMed ID: 15943853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipokines from local fat cells shape the macrophage compartment of the creeping fat in Crohn's disease.
    Kredel LI; Batra A; Stroh T; Kühl AA; Zeitz M; Erben U; Siegmund B
    Gut; 2013 Jun; 62(6):852-62. PubMed ID: 22543156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visceral adipocytes: old actors in obesity and new protagonists in Crohn's disease?
    Zulian A; Cancello R; Micheletto G; Gentilini D; Gilardini L; Danelli P; Invitti C
    Gut; 2012 Jan; 61(1):86-94. PubMed ID: 21930728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Levels of cytokines in mucosal biopsies of Crohn's colitis. Physiopatological observations].
    Marongiu L; Scintu F; Melis MV; Pisano M; Zorcolo L; Capra F; Casula G
    Minerva Chir; 2002 Feb; 57(1):35-40. PubMed ID: 11832856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visceral fat and gut inflammation.
    Drouet M; Dubuquoy L; Desreumaux P; Bertin B
    Nutrition; 2012 Feb; 28(2):113-7. PubMed ID: 22208553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of disease: adipocytokines and visceral adipose tissue--emerging role in intestinal and mesenteric diseases.
    Schäffler A; Schölmerich J; Büchler C
    Nat Clin Pract Gastroenterol Hepatol; 2005 Feb; 2(2):103-11. PubMed ID: 16265128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms.
    Kraaijeveld AO; de Jager SC; de Jager WJ; Prakken BJ; McColl SR; Haspels I; Putter H; van Berkel TJ; Nagelkerken L; Jukema JW; Biessen EA
    Circulation; 2007 Oct; 116(17):1931-41. PubMed ID: 17909104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different plasma levels of interleukins and chemokines: comparison between children and adults with AIDS in China.
    Jin CZ; Zhao Y; Zhang FJ; Yao HP; Wu LJ; Zhao HX; Wei HS; Wu NP
    Chin Med J (Engl); 2009 Mar; 122(5):530-5. PubMed ID: 19323903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crohn's disease intestinal CD4+ T cells have impaired interleukin-10 production which is not restored by probiotic bacteria.
    Hvas CL; Kelsen J; Agnholt J; Höllsberg P; Tvede M; Møller JK; Dahlerup JF
    Scand J Gastroenterol; 2007 May; 42(5):592-601. PubMed ID: 17454880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perinodal adipose tissue and fatty acid composition of lymphoid tissues in patients with and without Crohn's disease and their implications for the etiology and treatment of CD.
    Westcott ED; Mattacks CA; Windsor AC; Knight SC; Pond CM
    Ann N Y Acad Sci; 2006 Aug; 1072():395-400. PubMed ID: 17057221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fat intake and fatty acid profile in plasma phospholipids and adipose tissue in patients with Crohn's disease, compared with controls.
    Geerling BJ; v Houwelingen AC; Badart-Smook A; Stockbrügger RW; Brummer RJ
    Am J Gastroenterol; 1999 Feb; 94(2):410-7. PubMed ID: 10022638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective Th2 pattern of cytokine secretion in Mycobacterium avium subsp. paratuberculosis infected Crohn's disease.
    Ren Z; Turton J; Borody T; Pang G; Clancy R
    J Gastroenterol Hepatol; 2008 Feb; 23(2):310-4. PubMed ID: 18289359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-4 and TNF-alpha increased the secretion of eotaxin from cultured fibroblasts of nasal polyps with eosinophil infiltration.
    Yoshifuku K; Matsune S; Ohori J; Sagara Y; Fukuiwa T; Kurono Y
    Rhinology; 2007 Sep; 45(3):235-41. PubMed ID: 17956026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proinflammatory cytokines and IL-10 in inflammatory bowel disease and colorectal cancer patients.
    Szkaradkiewicz A; Marciniak R; Chudzicka-Strugała I; Wasilewska A; Drews M; Majewski P; Karpiński T; Zwoździak B
    Arch Immunol Ther Exp (Warsz); 2009; 57(4):291-4. PubMed ID: 19578817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A polymorphism in the macrophage migration inhibitory factor gene is involved in the genetic predisposition of Crohn's disease and associated with cumulative steroid doses.
    Griga T; Wilkens C; Wirkus N; Epplen J; Schmiegel W; Klein W
    Hepatogastroenterology; 2007; 54(75):784-6. PubMed ID: 17591062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.